Aigen Investment Management LP Sells 5,407 Shares of Encompass Health Corporation $EHC

Aigen Investment Management LP decreased its position in Encompass Health Corporation (NYSE:EHC) by 38.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 8,783 shares of the company’s stock after selling 5,407 shares during the quarter. Aigen Investment Management LP’s holdings in Encompass Health were worth $932,000 as of its most recent SEC filing.

A number of other institutional investors have also added to or reduced their stakes in the company. Northwestern Mutual Wealth Management Co. raised its holdings in Encompass Health by 3,059,159.7% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company’s stock worth $402,640,000 after purchasing an additional 3,793,358 shares in the last quarter. Alliancebernstein L.P. raised its holdings in Encompass Health by 23.4% in the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock worth $319,567,000 after purchasing an additional 476,564 shares in the last quarter. Geode Capital Management LLC raised its holdings in Encompass Health by 7.6% in the fourth quarter. Geode Capital Management LLC now owns 1,946,134 shares of the company’s stock worth $206,605,000 after purchasing an additional 137,892 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Encompass Health by 0.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,624,137 shares of the company’s stock worth $172,396,000 after purchasing an additional 7,959 shares in the last quarter. Finally, Raymond James Financial Inc. raised its holdings in Encompass Health by 34.8% in the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock worth $195,780,000 after purchasing an additional 397,694 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Leerink Partners set a $152.00 price target on Encompass Health in a report on Friday, May 22nd. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. TD Cowen assumed coverage on Encompass Health in a report on Thursday, May 28th. They set a “buy” rating and a $125.00 price target for the company. Weiss Ratings restated a “buy (b-)” rating on shares of Encompass Health in a report on Monday, June 8th. Finally, Barclays reduced their price target on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $143.86.

Encompass Health Trading Up 0.0%

Encompass Health stock opened at $101.49 on Monday. The company has a debt-to-equity ratio of 0.76, a current ratio of 1.17 and a quick ratio of 1.17. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99. The stock has a market capitalization of $10.07 billion, a PE ratio of 16.94, a price-to-earnings-growth ratio of 2.21 and a beta of 0.72. The business’s fifty day moving average is $104.31 and its 200 day moving average is $104.59.

Encompass Health (NYSE:EHC) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. During the same period last year, the firm posted $1.37 earnings per share. Encompass Health’s revenue was up 9.0% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, sell-side analysts predict that Encompass Health Corporation will post 5.97 EPS for the current year.

Encompass Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Wednesday, July 1st. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. Encompass Health’s dividend payout ratio (DPR) is 12.69%.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president directly owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This trade represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.80% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.